Article
Genetic Variants in ASCT2 Gene are Associated with the Prognosis of Transarterial Chemoembolisation-Treated Early- Stage Hepatocelluar Carcinoma.
Asian Pacific journal of cancer prevention : APJCP - 1 Jan 2015
Ge Nai-Jian, Shi Zhi-Yong, Yu Xiao-He, Huang Xiao-Jun, Wu You-Sheng, Chen Yuan-Yuan, Zhang Jin, Yang Ye-Fa
Abstract excerpt
BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies worldwide. Transarterial chemoembolisation (TACE) is the standardized therapy for intermediate stage HCC. However, the prognosis for HCC patients treated by TACE greatly varies. Thus, there is a critical need for finding biomarkers to predict the prognosis of HCC patients. The amino acid transporter-2 (ASCT2) is involved in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
